Overall, these findings describe an unusual role of CD8+ cells in RCC as high numbers of CD8+ cells are strongly linked to favorable prognosis in most other cancer types including advanced urothelial cancer [41], breast cancer [42], pancreatic carcinomas [43], colorectal cancer [44] and others. Here, CD8A is linked to exocrine pancreatic carcinoma.